Home Sequential Compression Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Device Type (Alternate Sequential Compression Device (ASCD), Simultaneous Sequential Compression Device (SSCD)); Type (Standard, PORTABLE); Application (Deep Vein Thrombosis, Lymphedema Management, Chronic Venous Insufficiency (CVI), Others), and Geography
Publication Month: Jul 2021 | Report Code: TIPRE00019265 | No. of Pages: 177 | Category: Medical Device | Status: Published
The home sequential compression devices market was valued at US$ 992.49 million in 2021 and is projected to reach US$ 1,572.81 million by 2028; it is expected to grow at a CAGR of 6.8% from 2021 to 2028.
The home sequential compression device (SCD) is a DVT prevention device that increases leg blood flow. SCDs are in the shape of "sleeves" that wrap around the legs and inflate one at a time using air. This simulates walking and aids in the prevention of blood clots. When you're in bed or sitting in a chair, the one should wear SCDs. For walking, the SCDs must be removed. The home sequential compression devices market is expected to witness a significant growth in the coming years owing to the factors such as rise prevalence of lymphatic and venous disorders and increasing awareness about the advance treatment involve use of sequential compression and other devices are driving the market growth. However, availability of alternate therapies hampers the growth of the market.
Lucrative Regions for Home Sequential Compression Devices Market
Get more information on this report :
Market Insights
Prevalence of Lymphatic and Venous Disorders
Sequential compression devices (SCDs) are used as a part of venous thromboembolism (VTE). As per the Center for Disease Control and Prevention (CDC), blood clotting in a deep vein results in the VTE, which is primarily a condition of blood vessels. These clots generally develop in lower leg, thigh, or pelvis, and injury to veins, slow blood flow, increased estrogen levels, heart diseases, and obesity are among the main causes of the clot formation. As per a study published by StatPearls Publishing LLC in August 2020, more than 200,000 people in the US are reported to develop venous thrombosis annually. Moreover, as per the Thrombosis UK, 1 in 1000 people suffer from venous thrombosis every year. Venous disorders are caused due to factors such as pregnancy, obesity, varicose vein, and venous insufficiency. Venous insufficiency is observed in pregnancy mainly due to an enlarged gravid uterus, resulting in hypertension in the lower extremity veins and increased hormone secretion, weakening the vein walls. Thus, the rising prevalence of lymphatic and venous disorders is boosting the demand for home sequential compression device, thereby driving the market growth.
Device Type Insights
Based on device type, the home sequential compression devices market is segmented into segmented into alternate sequential compression device (ASCD) and simultaneous sequential compression device (SSCD). The simultaneous sequential compression device (SSCD) segment held a larger share of the market in 2021 and is anticipated to register a higher CAGR in the market during the forecast period.
Type Insights
Based on type, the home sequential compression devices market is segmented into standard and portable. In 2021, the standard segment is likely to hold a larger share of the market and is expected to grow at the fastest rate during the coming years.
Application
Based on application, the home sequential compression devices market is segmented into deep vein thrombosis (DVT), lymphedema management, chronic venous insufficiency (CVI), and others. The deep vein thrombosis (DVT) segment is likely to hold the largest share of the market in 2021 and is anticipated to register the highest CAGR of the market during the forecast period.
Home Sequential Compression Devices Market, by Device Type – 2021 and 2028
Get more information on this report :
Strategic Insights
Players operating in the home sequential compression devices market have been majorly adopting the product innovation strategy to cater to the changing customer demand across the world, which also permits them to maintain their brand name globally.
By Device Type
- Simultaneous Sequential Compression Device (SSCD))
- Alternate Sequential Compression Device (ASCD)
By Type
- Standard
- Portable
By Application
- Deep Vein Thrombosis (DVT)
- Lymphedema Management
- Chronic Venous Insufficiency (CVI)
By Geography
North America
- US
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
South and Central America
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Cardinal Health Inc
- BIOCOMPRESSION SYSTEMS
- DJO Global, Inc.
- DSMAREF CO.LTD
- Precision Medical Products
- AIROS Medical
- Breg Inc.
- Mego Afek ltd.
- Arjo Medical Devices
- Tactile Medical
The List of Companies - Home Sequential Compression Devices Market
- Cardinal Health Inc
- Biocompression Systems
- DJO Global, Inc.
- DS MAREF CO.LTD
- Precision Medical Products
- AIROS Medical
- Breg Inc.
- Mego Afek ltd.
- Arjo Medical Devices
- Tactile Medical
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the home sequential compression devices market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global home sequential compression devices market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
-
$3000 $2700
$4550 $4095$6550 $5568$8550 $6840Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount
